Viewing StudyNCT06374602



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2025-12-17 @ 3:38 PM
Study NCT ID: NCT06374602
Status: None
Last Update Posted: 2025-09-05 00:00:00
First Post: 2024-03-27 00:00:00

Brief Title: Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Sponsor: Saint Petersburg State University Russia
Organization: Saint Petersburg State University, Russia

Conditions & Keywords Data

Conditions:
Name
Anaplastic Thyroid Cancer
Keywords:
Name View
Pembrolizumab View
Anaplastic thyroid cancer View
Immunotherapy View
Targeted therapy View
Lenvatinib View